Benuvia Secures ANVISA CBPF Certification for Pharmaceutical Manufacturing in Brazil

• Benuvia Operations, LLC has received Good Manufacturing Practices (GMP) certification (CBPF) from Brazil’s National Health Surveillance Agency (ANVISA).

• The certification enables Benuvia to manufacture non-sterile liquid pharmaceutical products for the Brazilian market and international companies seeking compliant production.

Benuvia Operations, LLC has been awarded Good Manufacturing Practices (GMP) certification (Certificado de Boas Práticas de Fabricação or CBPF) from Brazil’s National Health Surveillance Agency (ANVISA). This certification allows the company to manufacture and distribute non-sterile liquid pharmaceutical products in Brazil, the largest healthcare market in Latin America.

The ANVISA CBPF certification is a crucial regulatory requirement for pharmaceutical companies operating in Brazil. It signifies compliance with stringent local manufacturing standards, facilitating quicker market entry and reducing regulatory hurdles for pharmaceutical firms looking to establish a presence in the country.

Terry Novak, CEO of Benuvia, highlighted the significance of the achievement, stating, “Achieving ANVISA’s CBPF certification underscores Benuvia’s strategic commitment to providing high-quality, compliant pharmaceutical manufacturing specifically tailored to Brazil’s rapidly growing healthcare market.”

With this certification, Benuvia strengthens its position as a CDMO, offering contract manufacturing services to both domestic and international pharmaceutical companies. The approval enhances Benuvia’s credibility among regulatory bodies, healthcare providers, and pharmaceutical customers seeking reliable manufacturing partners in Brazil.